BIOVENTUS INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+2.8% +$4M
$158M
Cost of Revenue↓-3.7% -$2M
$49M
Gross Profit↑+6.0% +$6M
$109M
R&D↓-8.1% -$264K
$3M
SG&A↓-4.7% -$4M
$83M
D&A↓-5.7% -$711K
$12M
Operating Income
$19M
EBITDA↑+151.4% +$19M
$31M
Interest Expense↑+35.2% +$3M
$-6M
Other Income/Expense
$-5M
Pretax Income
$14M
Tax Provision↑+12.7% +$75K
$664K
Net Income
$15M
Gross Margin↑+2.1pts
68.9%
Operating Margin
12.3%
Net Margin
9.3%
Effective Tax Rate↑+25.4pts
14.2%
Deferred Tax Assets↓-100.0% -$512K
$0
Deferred Tax Liabilities
$135K
Tax Credit Carryforwards↑+126.0% +$1M
$2M
ETR (Continuing Operations)↓-16.2pts
-6.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-1.2pts
1.0%
ETR Foreign Differential (pp)
-0.6%
Operating Lease Cost↓-18.3% -$144K
$642K
Revenue YoY Variation↓-10.7pts
2.8%
Income YoY Variation↑+157.7pts
208.5%
Revenue QoQ Variation↑+3.3pts
13.9%
Income QoQ Variation
73.2%